Double-blind, placebo-controlled, multicenter trial of selegiline augmentation of antipsychotic medication to treat negative symptoms in outpatients with schizophrenia

American Journal of Psychiatry

Volumn 162, Issue 2, 2005, Pages 388-390

  Bodkin, J Alexander ^a   Siris, Samuel G ^b   Bermanzohn, Paul C ^b   Hennen, John ^b   Cole, Jonathan O ^b  

^a MCLEAN HOSPITAL   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

NEUROLEPTIC AGENT; SELEGILINE;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEPRESSION; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; FEMALE; HUMAN; MALE; MULTICENTER STUDY; OUTPATIENT; PRIORITY JOURNAL; SCHIZOPHRENIA;

ADMINISTRATION, ORAL; ADULT; AMBULATORY CARE; ANTIPSYCHOTIC AGENTS; DOUBLE-BLIND METHOD; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; MALE; MONOAMINE OXIDASE INHIBITORS; PLACEBOS; PSYCHIATRIC STATUS RATING SCALES; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY; SELEGILINE; TREATMENT OUTCOME;

EID: 13444271621     PISSN: 0002953X     EISSN: None     Source Type: Journal    
DOI: 10.1176/appi.ajp.162.2.388     Document Type: Article

References (12)

1. Goff DC, Evins AE: Negative symptoms in schizophrenia: neurobiological models and treatment response. Harv Rev Psychiatry 1998; 6:59-77
2. Bermanzohn PC, Siris SG: Akinesia: a syndrome common to parkinsonism, retarded depression, and negative symptoms of schizophrenia. Compr Psychiatry 1992; 33:221-232
3. Davis KL, Kahn RS, Ko G, Davidson M: Dopamine in schizophrenia: a review and reconceptualization. Am J Psychiatry 1991; 148:1474-1486
4. Bodkin JA, Cohen BJ, Salomon MS, Cannon SE, Zornberg GL, Cole JO: Treatment of negative symptoms of schizophrenia and schizoaffective disorder by selegiline augmentation of antipsychotic medication: a pilot study examining the role of dopamine. J Nerv Ment Dis 1996; 184:295-301
5. Perenyi A, Goswami U, Frecksa E, Arato M, Bela A: L-Deprenyl in treating negative symptoms of schizophrenia. Psychiatry Res 1992; 42:189-191
6. Gupta S, Droney T, Kyser A, Keller P: Selegiline augmentation of antipsychotics for the treatment of negative symptoms in schizophrenia. Compr Psychiatry 1999; 40:148-150
7. Goff DC, Renshaw PF, Sarid-Segal O, Dreyfus D, Amico ET, Ciraulo DA: A placebo-controlled trial of selegiline (L-deprenyl) in the treatment of tardive dyskinesia. Biol Psychiatry 1993; 33:700-706
8. Jungerman T, Rabinowitz D, Klein E: Deprenyl augmentation for treating negative symptoms of schizophrenia: a double-blind, controlled study. J Clin Psychopharmacol 1999; 19:522-525
9. Bodkin JA, Kwon AE: Selegiline and other atypical monoamine oxidase inhibitors in depression. Psychiatr Annals 2001; 31:385-391
10. Siris SG, van Kammen DP, Docherty JP: Use of antidepressant drugs in schizophrenia. Arch Gen Psychiatry 1978; 35:1368-1377
11. Cole JO, Jones RT, Klerman GL: Drug Therapy. Prog Neurol Psychiatry 1961; 16:539-574
12. Brenner R, Shopsin B: The use of monoamine oxidase inhibitors in schizophrenia. Biol Psychiatry 1980; 15:633-647